Stage 4 Bladder Cancer: Metastatic Symptoms and Life Expectancy

Stage 4 bladder cancer is an advanced oncological condition characterized by tumor cells spreading beyond the urinary bladder to distant tissues such as the bones, lungs, or liver. The metastatic symptoms that occur at this stage consist of systemic problems such as persistent bone pain, shortness of breath, loss of appetite, and sudden weight loss, in addition to local complaints such as heavy blood clots in the urine. Although overall life expectancy at this stage statistically declines, with five-year survival rates falling to approximately 10-15%, the individual lifespan of the patient varies entirely from person to person according to general health status, the rate of tumor spread, and cellular responses to new-generation targeted drug treatments.

How Does Stage 4 Bladder Cancer Develop Anatomically and Into Which Subgroups Is It Divided?

The urinary bladder is an anatomical organ located in the pelvic cavity, composed of flexible muscle fibers, and responsible for storing urine filtered by the kidneys until it is expelled from the body. On the inner surface of this sac is a special layer of cells called the urothelium, which is resistant to the acidic nature of urine. The disease usually begins in this superficial cell layer. Cells that may initially cause no symptoms or progress insidiously tend over time to gradually move beyond this superficial layer toward the dense muscle tissue deeper within the bladder wall. Cells that pass through the muscle layer and reach the fatty membrane surrounding the outside of the bladder may then spread to neighboring organs, supporting tissues, or directly into the vascular system. To understand how far the disease has spread and to establish an accurate basis for the systemic or local treatment plan, we use an international staging and classification system based on anatomical spread.

In clinical practice, stage 4 disease is generally divided into two main subcategories according to the areas to which the cells have spread. In the first condition, Stage IVA, the tumor may have completely penetrated all layers of the bladder wall and directly advanced into the inner walls of the pelvis, the prostate, uterine tissue, or the abdominal cavity. At the same time, microscopic or macroscopic involvement may also be seen in the regional lymph nodes near the bladder, which serve as sentinels of the immune system. At this stage, although the cancer cells may not yet have reached very distant vital organs, they have clearly crossed the regional safety boundary around the bladder. In Stage IVB, the clinical situation takes on a somewhat different dimension. Here, the cancer cells have entered the main pathways of the circulatory system and migrated far beyond the pelvic region where they first originated. When they establish new sites in distant organs such as the lungs, liver, or bone tissue through the circulation, this is medically referred to as distant metastasis. This distinction provides important guidance in determining the treatment alternatives we offer to patients.

Which Local Urinary Tract Symptoms Occur During Stage 4 Bladder Cancer?

At this advanced stage of the disease, the physical changes caused by the growing tumor mass within the bladder may lead to noticeable and sometimes sudden differences in urine storage and emptying habits. The main regional symptoms directly involving the urinary tract and leading the person to seek medical care are as follows:

• Painless bleeding
• Blood clots in the urine
• Frequent need to urinate
• Burning during urination
• Weakening of urine flow
• Intermittent urine flow
• Sudden urinary urgency
• Inability to urinate

The most common and clinically important of these symptoms is generally visible blood in the urine. This bleeding, which often causes no pain, occurs because the new blood vessels forming on the tumor tissue are highly delicate and fragile. Sometimes the bleeding may be intermittent, leading the person to think that the problem has resolved on its own; however, over time, the bleeding may become so intense that large blood clots accumulate inside the bladder. The tumor mass that continuously irritates the inner surface of the bladder may impair the organ’s natural elasticity and urine-holding capacity. This may cause a constant feeling of fullness to be transmitted to the brain even before the bladder is full, leading the person to feel the need to urinate day and night. In addition, in anatomical situations where the tumor mechanically blocks the bladder outlet, known as the bladder neck, or the openings where the thin channels from the kidneys enter the bladder, urine flow may be seriously obstructed. Situations in which the bladder becomes completely full and urine cannot be expelled require emergency medical evaluation to protect the kidneys and relieve the patient.

Which Systemic Symptoms Does Metastatic Stage 4 Bladder Cancer Trigger in Distant Organs?

When cancer cells move beyond the boundaries of the urinary bladder and settle in different biological areas of the body, a wide variety of exhausting symptoms specific to the function of the affected organs may arise in addition to urinary tract problems. The systemic complaints we frequently observe in patients during distant organ spread are as follows:

• Persistent feeling of fatigue
• Unintentional weight loss
• Decreased appetite
• Bone aches
• Shortness of breath
• Persistent coughing attacks
• Upper right abdominal pain
• Swelling in the legs
• Yellowing of the skin

The primary reason for these systemic symptoms is that cancer cells occupy space in the tissues of the organs they reach and consume the energy required for those organs to function properly. For example, cells that settle in bone tissue may weaken the mineral structure of the bone and cause deep pain that tends to worsen at night, is triggered by movement, and does not easily resolve with rest. Cellular spread to the lung tissue may affect breathing capacity, leaving the person short of breath even while performing simple household tasks or causing persistent coughing by irritating the airways. Cellular involvement in the liver may slow the organ’s filtering function, contributing to digestive problems, reduced interest in food, and signs such as yellowing of the skin due to the accumulation of substances in the blood. If the large lymph nodes behind the abdomen become blocked, tissue fluid returning from the lower body may become trapped in the legs and cause swelling known as regional edema. The body being in a continuous state of defense and struggle may consume overall metabolic energy and lead to profound fatigue that does not improve with rest.

Which Imaging Methods Are Used to Confirm the Diagnosis of Stage 4 Bladder Cancer?

When an individual presents with complaints such as blood in the urine or unexplained bone pain, we begin a comprehensive examination process to clearly determine the true source of the problem and map the disease throughout the body in detail. The methods we use to confirm the diagnosis and establish the stage are as follows:

• Cystoscopy procedure
• Tissue biopsy
• Computed tomography
• Magnetic resonance imaging
• Positron emission tomography
• Biochemical blood tests
• Liver enzyme panels

The first and perhaps most critical step in the process is cystoscopy, in which we enter through the urinary tract with a very thin flexible or rigid optical instrument equipped with a camera and directly examine the internal structure of the bladder. If we see a suspicious polyp-like or raised lesion with increased blood vessel formation inside the bladder, we obtain small tissue samples from it using special instruments for a definitive diagnosis and send them to specialist pathologists for cellular examination. Once the presence of cancer has been confirmed under the microscope, the next most important step is to determine the extent of the disease in body cavities outside the bladder. For this purpose, we use tomography systems that produce cross-sectional images of the body at millimetric resolution and magnetic resonance systems with very high soft tissue resolution. Positron emission tomography, which works by highlighting cellular sugar consumption, may provide valuable support in detecting cancerous tissues anywhere in the body that use more energy than normal. Certain biochemical values measured in the blood may also provide us with additional clues regarding the function of the bones or liver.

What Do Life Expectancy Statistics Mean in Stage 4 Bladder Cancer Cases?

At advanced stages of the disease, life expectancy is one of the most challenging issues for patients and their relatives, yet it is a multidimensional matter that depends on many medical and personal factors and may vary greatly from one patient to another. Compared with cases detected at an early stage while confined to the inner surface of the bladder, survival rates tend to be lower according to statistical data in advanced stages and especially in cases involving distant organ metastasis. However, there is one very important point that should not be forgotten: statistics are mathematical averages obtained from the historical data of thousands of people, and because medicine is constantly evolving, they cannot predict any individual’s personal story or future with complete certainty. Our main goal in treatment planning is to slow the rate of disease progression with the medical regimens applied, minimize symptoms such as pain, and provide the person with the highest possible quality of life together with their loved ones.

When large oncological healthcare databases are examined, five-year relative survival rates are more encouraging when the disease remains limited to the bladder wall, whereas these statistical percentages tend to decline significantly when it reaches regional lymphatic networks, surrounding bones, or distant organs such as the lungs. However, when sharing these data with our patients, we always emphasize the following: the biological behavior of the tumor, the person’s general health status, the strength of the heart or kidneys, and the cellular responses of the body to new-generation treatments may profoundly influence the process. Particularly in individuals who successfully complete the first year during which the disease is kept under control with current treatments, adaptation of the body to therapy may increase and the likelihood of spending subsequent years in a more stable condition may improve. Thanks to the remarkable innovations and smart molecules emerging in medicine, our chances of encountering longer-lasting and more promising clinical outcomes increase every day.

What Can Be Done Urologically When Stage 4 Bladder Cancer Places Pressure on the Kidneys?

A large advanced bladder tumor or lymph nodes that have enlarged and hardened in surrounding tissues may exert external mechanical pressure on the thin channels, known as the ureters, that continuously carry urine from the kidneys to the bladder. This may prevent urine from flowing freely downward toward the bladder, causing it to accumulate backward in the kidney’s collecting system and gradually lead to swelling of the organ. The urological methods we use to preserve the filtering capacity of the kidneys are as follows:

• Cystoscopic stent placement
• Percutaneous nephrostomy procedure
• Urinary tract decompression

If the liquid waste produced by the kidneys as they filter the blood cannot be regularly removed from the body, kidney cells may gradually slow their function, and harmful substances such as urea may accumulate in the blood at dangerous levels. More importantly, the kidneys must function at full capacity so that systemic medications used in the oncological treatment can be eliminated from the body in a healthy and safe manner. Therefore, to keep the compressed urinary channels open from the inside, we may enter through the urinary tract using a closed system and place a thin, flexible plastic tube with curled ends, known as a stent, into the obstructed area. This tube may help urine flow into the bladder by creating a secure tunnel despite the external pressure of the mass. In difficult situations where placing a stent from within the bladder is not possible or safe due to the anatomical location of the tumor, the swollen kidney collecting system may be reached directly through the back with a very thin needle under ultrasound guidance, and the urine may be drained into an external sterile bag. These protective interventions are vitally important not only for preventing structural damage to the kidneys but also for allowing the patient to begin general oncological treatments safely and without delay.

Which Methods Are Used for Bleeding Caused by Stage 4 Bladder Cancer?

The new blood vessels forming on the surface of advanced bladder tumors are structurally extremely thin and may sometimes rupture spontaneously and begin bleeding during the filling and emptying movements of the bladder. The methods we use to control this bleeding, which may clot and completely obstruct the urinary tract and cause severe anemia in the patient, are as follows:

• Special intravesical irrigations
• Alum solution application
• Silver nitrate solution
• Chemical cauterization with formalin
• Arterial embolization procedures
• Regional palliative radiotherapy

As the first step, we generally continuously irrigate the bladder by sending specially prepared cold chemical solutions into it through a large-diameter catheter placed in the urinary tract. These solutions may help slow or stop bleeding by constricting and coagulating the ends of the numerous small bleeding vessels. If standard intravesical irrigation is insufficient to stop the bleeding, a specially concentrated formalin solution, which is a stronger chemical agent, may be kept inside the bladder in a controlled manner for a specific period to chemically seal the bleeding tissue surfaces. In difficult cases where all of these regional methods applied inside the bladder fail and bleeding continues persistently, angiographic entry through the groin in coordination with interventional radiology specialists may be considered to block the arteries directly supplying the bladder. Sometimes, several sessions of low-dose radiotherapy planned externally to the bladder region by radiation oncology specialists may also provide a significant and lasting contribution to bleeding control by narrowing the blood vessels.

Which Surgical Procedures May Be Considered for Stage 4 Bladder Cancer?

Even when the disease has completely extended beyond the bladder and spread to distant regions, major surgical options may need to be discussed with the patient and relatives in certain highly specific and selected circumstances. In particular, if the continuously growing mass inside the bladder causes pelvic pain that cannot be controlled with medication, recurrent massive bleeding that exhausts the body, or severe infections by creating openings called fistulas into neighboring intestinal tissues, complete surgical removal of the bladder may be considered to preserve the patient’s daily quality of life. The medical purpose of this type of surgery is not to completely eliminate and cure the disease from the body, but to relieve the body and mind by removing the main source of the problems causing severe suffering.

When the bladder is removed, a new drainage system must be established so that urine continuously filtered by the kidneys can be safely expelled from the body. We call this surgical procedure urinary diversion. Generally, a short segment of the patient’s own small intestine is removed, the ureters are connected to this new segment, and urine is directed to continuously flow into a specially adhesive external bag surgically attached to the abdominal area. In advanced cancer and in patients whose general health is poor, creating a new neobladder through prolonged intestinal surgery may not be preferred because it may be risky and because of the nature of the disease. If the patient’s general condition appears unable to tolerate such a major and radical operation, the tumors inside the bladder may simply be shaved and reduced through a closed endoscopic procedure performed through the urinary tract. Even this smaller intervention may help increase the internal capacity of the bladder, allow the patient to urinate relatively more comfortably, and improve the effectiveness of medications.

What Is the Role of Chemotherapy in the Treatment of Stage 4 Bladder Cancer?

When the disease leaves its original site and spreads throughout the body through the circulatory system, we need powerful systemic treatments that circulate through all body tissues, going far beyond regional interventions. One of the fundamental pillars of this difficult struggle for many years has been systemic chemotherapy planned and administered by medical oncology specialists. Chemotherapy drugs are generally delivered into the bloodstream intravenously in sessions, circulate through the blood vessels throughout the body, and aim to stop the growth of or destroy cancer cells by damaging the genetic structures of cells that divide rapidly and uncontrollably. In stage 4 bladder cancer, provided that the patient’s kidneys allow it, combinations of highly effective drugs commonly referred to as platinum-based regimens are frequently preferred.

Although these drugs have a destructive effect on cancer cells, by their nature they may also temporarily affect certain healthy and rapidly dividing cells in the body, such as hair follicles or the stomach lining. This appears in clinical practice as side effects that need to be managed. During chemotherapy cycles, nausea, general weakness, hair loss, and certain decreases in blood counts may occur. In particular, some powerful medications may cause effects involving nerve cells, such as tingling, pins-and-needles sensations, or mild loss of sensation in the fingertips and toes. Because a significant portion of the drugs used in treatment is eliminated directly through the kidneys, we must monitor kidney function tests very closely before each chemotherapy session. Since decreases in blood cells may weaken the body’s resistance to infections, protective support injections that externally stimulate the bone marrow and increase white blood cell production may be included in the treatment regimen. Every difficulty experienced by the patient throughout the process may be closely monitored and managed with various supportive anti-nausea medications or vitamins.

How Are Immunotherapy and Targeted Drugs Used in the Management of Stage 4 Bladder Cancer?

One of the most exciting advances made by medical science in cancer care in recent years is the introduction of immunotherapy agents that reprogram the body’s own natural defense mechanism against cancer, unlike the directly toxic effect of chemotherapy, as well as smart drugs that target only the genetic defects of cancer cells. The methods we use in these new-generation innovative treatments are as follows:

• Immune system stimulators
• Cellular checkpoint inhibitors
• Targeted genetic agents
• Antibody-linked molecules

Cancer cells in our body carry special false proteins on their surfaces that make them appear like healthy cells so that they can hide from the patrolling cells of the immune system. When immunotherapy drugs enter the bloodstream, they may help break down this cellular invisibility shield used by cancer cells, enabling the body’s own defense cells to recognize the tumor as a threat and attack it. This treatment may sometimes be used to maintain the state of improvement achieved after chemotherapy for months, and at other times as a rescue strategy when chemotherapy proves insufficient. Because immunotherapy strongly stimulates the immune system, it may sometimes cause side effects in healthy tissues, such as thyroid problems or skin rashes.

Another groundbreaking innovation, targeted smart drugs, focuses on mutations in specific growth genes detected when a detailed genetic map of the tumor is prepared in the laboratory. These drugs attempt to directly interrupt the growth and proliferation signals of cancer cells without damaging healthy cells. Molecules that combine antibodies with drugs, which have recently become widely known, function like microscopically guided cargo aircraft; they identify only a specific protein on the surface of bladder cancer cells in the circulation, enter the cell, and deliver the powerful drug they carry directly into the cell nucleus. In this way, surrounding tissues sustain minimal damage. Since the genetic structure and biological fingerprint of each patient’s tumor are different, the stage at which these highly modern treatments should be applied and to whom is carefully determined by our multidisciplinary boards in light of genetic testing.

Frequently Asked Questions

Prof. Dr. Yılören TANIDIR

Prof. Dr. Yılören Tanıdır is a urology specialist who graduated from Hacettepe University Faculty of Medicine in 2001 and completed his urology residency at Marmara University Faculty of Medicine. Tanıdır, who works at Medicana Ataşehir Hospital, specializes in endourology, laparoscopy, robotic surgery, and pediatric urology (hypospadias, neurogenic bladder).